Δ14-Triamcinolone acetonide

Δ14-Triamcinolone acetonide is a potential impurity. Triamcinolone acetonide inhibits basic fibroblast growth factor (bFGF) induced proliferation of retinal endothelial cells. Triamcinolone acetonide reduces chondrocyte viability and leads to cartilage destruction. Triamcinolone acetonide can be used in the study of diseases such as atopic dermatitis[1].

Product Specifications

CAS Number

[1260149-96-9]

UNSPSC

12352005

Hazard Statement

H302, H360

Target

Drug Intermediate

Related Pathways

Others

Field of Research

Cancer; Endocrinology; Inflammation/Immunology

Smiles

OCC([C@]12[C@@]3(C([C@@]4([H])[C@]([C@H](C3)O)([C@@]5(C(CC4)=CC(C=C5)=O)C)F)=C[C@@]1([H])OC(C)(O2)C)C)=O

Molecular Formula

C24H29FO6

Molecular Weight

432.48

Precautions

H302, H360

References & Citations

[1]G Cavina, et al. The identification of related substances in triamcinolone acetonide by means of high-performance liquid chromatography with diode array detector and mass spectrometry. J Pharm Biomed Anal. 1992 Sep;10 (9) :685-92.